{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:27:18Z","timestamp":1794619638603,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016580","name":"Kennedy Trust for Rheumatology Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016580","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000861","name":"Sparks","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019256","name":"NIHR Great Ormond Street Hospital Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001279","name":"Great Ormond Street Hospital Children's Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ard.2025.03.007","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:42:57Z","timestamp":1747755777000},"page":"1412-1424","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-393X","authenticated-orcid":false,"given":"Melissa","family":"Kartawinata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-7988","authenticated-orcid":false,"given":"Wei-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Jebson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-7084","authenticated-orcid":false,"given":"Elizabeth","family":"Ralph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8434-4465","authenticated-orcid":false,"given":"Restuadi","family":"Restuadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4800-4695","authenticated-orcid":false,"given":"Elizabeth C.","family":"Rosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7044-5801","authenticated-orcid":false,"given":"Claire T.","family":"Deakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7495-1429","authenticated-orcid":false,"given":"Lucy R.","family":"Wedderburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9755-1703","authenticated-orcid":false,"given":"Chris","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ard.2025.03.007_bib0001","first-page":"390","article-title":"International League of Associations for Rheumatology Classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2025.03.007_bib0002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/acr.23853","article-title":"Long-term outcomes in juvenile idiopathic arthritis: eighteen years of follow-up in the population-based Nordic juvenile idiopathic arthritis cohort","volume":"72","author":"Glerup","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"6","key":"10.1016\/j.ard.2025.03.007_bib0003","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1136\/annrheumdis-2014-207164","article-title":"The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort","volume":"75","author":"Guzman","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12969-023-00898-5","article-title":"\u2018The current mental health status of children and young people with JIA, and their wider family\u2019: a charity partner collaboration survey","volume":"21","author":"Livermore","year":"2023","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0005","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","article-title":"Juvenile idiopathic arthritis","volume":"8","author":"Martini","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.ard.2025.03.007_bib0006","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2014.212","article-title":"Management of juvenile idiopathic arthritis: hitting the target","volume":"11","author":"Hinze","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ard.2025.03.007_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104946","article-title":"Towards stratified treatment of JIA: machine learning identifies subtypes in response to methotrexate from four UK cohorts","volume":"100","author":"Shoop-Worrall","year":"2024","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ard.2025.03.007_bib0008","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/ard-2022-222553","article-title":"Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis","volume":"82","author":"Wedderburn","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2025.03.007_bib0009","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9005.1","article-title":"RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR","volume":"5","author":"Law","year":"2016","journal-title":"F1000Res."},{"issue":"7","key":"10.1016\/j.ard.2025.03.007_bib0010","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.ard.2025.03.007_bib0011","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","article-title":"Voom: precision weights unlock linear model analysis tools for RNA-seq read counts","volume":"15","author":"Law","year":"2014","journal-title":"Genome Biol"},{"issue":"43","key":"10.1016\/j.ard.2025.03.007_bib0012","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ard.2025.03.007_bib0013","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kex206","article-title":"Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate","volume":"56","author":"Moncrieffe","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0014","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41597-022-01264-y","article-title":"RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients","volume":"9","year":"2022","journal-title":"Sci Data"},{"issue":"12","key":"10.1016\/j.ard.2025.03.007_bib0015","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2012-202031","article-title":"Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis","volume":"72","author":"McErlane","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ard.2025.03.007_bib0016","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ard.2025.03.007_bib0017","doi-asserted-by":"crossref","unstructured":"Korotkevich G, Sukhov V, Sergushichev A. fgsea: fast gene set enrichment analysis. 2023. https:\/\/doi.org\/10.1101\/060012.","DOI":"10.1101\/060012"},{"issue":"6","key":"10.1016\/j.ard.2025.03.007_bib0018","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"issue":"database issue","key":"10.1016\/j.ard.2025.03.007_bib0019","doi-asserted-by":"crossref","first-page":"D852","DOI":"10.1093\/nar\/gkn732","article-title":"INTERFEROME: the database of interferon regulated genes","volume":"37","author":"Samarajiwa","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.ard.2025.03.007_bib0020","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/rheumatology\/keab601","article-title":"Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response","volume":"61","author":"Lerkvaleekul","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-001934","article-title":"SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies","volume":"8","author":"Graf","year":"2022","journal-title":"RMD Open"},{"issue":"14","key":"10.1016\/j.ard.2025.03.007_bib0022","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1177\/0961203320965699","article-title":"SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus","volume":"29","author":"Stuckrad","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.ard.2025.03.007_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109329","article-title":"CD169 expression on monocytes as a marker for assessing type I interferon status in pediatric inflammatory diseases","volume":"250","author":"Sakumura","year":"2023","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2017.08.026","article-title":"The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy","volume":"141","author":"Cooles","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0025","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2665-9913(21)00254-X","article-title":"The interferon gene signature as a clinically relevant biomarker in autoimmune rheumatic disease","volume":"4","author":"Cooles","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ard.2025.03.007_bib0026","doi-asserted-by":"crossref","unstructured":"Plant D, Maciejewski M, Smith S, Nair N, Maximising Therapeutic Utility in Rheumatoid Arthritis Consortium, the RAMS Study Group, et al. Profiling of gene expression biomarkers as a classifier of methotrexate nonresponse in patients with rheumatoid arthritis. Arthritis Rheumatol. 2019;71(5):678-84. doi:10.1002\/art.40810","DOI":"10.1002\/art.40810"},{"issue":"8","key":"10.1016\/j.ard.2025.03.007_bib0027","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/rheumatology\/ket152","article-title":"A subgroup of juvenile idiopathic arthritis patients who respond well to methotrexate are identified by the serum biomarker MRP8\/14 protein","volume":"52","author":"Moncrieffe","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.ard.2025.03.007_bib0028","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/FPC.0b013e32833f2cd0","article-title":"Generation of novel pharmacogenomic candidates in response to methotrexate in juvenile idiopathic arthritis: correlation between gene expression and genotype","volume":"20","author":"Moncrieffe","year":"2010","journal-title":"Pharmacogenet Genomics"},{"issue":"12","key":"10.1016\/j.ard.2025.03.007_bib0029","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"15","key":"10.1016\/j.ard.2025.03.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121544","article-title":"Identification of enhanced IFN-\u03b3 signaling in polyarticular juvenile idiopathic arthritis with mass cytometry","volume":"3","author":"Throm","year":"2018","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.ard.2025.03.007_bib0031","first-page":"1548","article-title":"Type I interferon signature as a possible new marker for stratification of patients with juvenile idiopathic arthritis","volume":"41","author":"De Nardi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ard.2025.03.007_bib0032","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.848168","article-title":"Increased development of Th1, Th17, and Th1.17 cells under T1 polarizing conditions in juvenile idiopathic arthritis","volume":"13","author":"Patrick","year":"2022","journal-title":"Front Immunol"},{"issue":"Suppl 9","key":"10.1016\/j.ard.2025.03.007_bib0033","article-title":"Inflammatory arthritis across the age-spectrum: single-cell profiling of the inflamed synovium in children with juvenile idiopathic arthritis","volume":"75","author":"Bolton","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.03.007_bib0034","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13075-016-1065-3","article-title":"The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes","volume":"18","author":"de Jong","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/art.24087","article-title":"Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis","volume":"61","author":"Albers","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ard.2025.03.007_bib0036","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13073-015-0227-2","article-title":"Dynamic tracking of functional gene modules in treated juvenile idiopathic arthritis","volume":"7","author":"Du","year":"2015","journal-title":"Genome Med"},{"issue":"8","key":"10.1016\/j.ard.2025.03.007_bib0037","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/ard.2010.146191","article-title":"Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis","volume":"70","author":"Hinks","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ard.2025.03.007_bib0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089908","article-title":"A novel dried blood spot-LCMS method for the quantification of methotrexate polyglutamates as a potential marker for methotrexate use in children","volume":"9","author":"Hawwa","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ard.2025.03.007_bib0039","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1546-0096-11-23","article-title":"Mothers\u2019 reports of the difficulties that their children experience in taking methotrexate for juvenile idiopathic arthritis and how these impact on quality of life","volume":"11","author":"Mulligan","year":"2013","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.ard.2025.03.007_bib0040","doi-asserted-by":"crossref","unstructured":"Kartawinata M, Lin W-Y, Jebson B, O'Brien K, Ralph E, Restuadi R, et al. P180 Interferon pathways are associated with the response to methotrexate treatment in juvenile idiopathic arthritis. In: Proceedings of the 31st European Paediatric Rheumatology Congress: part 2. Pediatr Rheumatol. 2024;22 Suppl 2:PReS24-ABS-1280. https:\/\/doi.org\/10.1186\/s12969-024-01005-y.","DOI":"10.1186\/s12969-024-01005-y"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725008234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T04:13:02Z","timestamp":1778386382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725008234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0003496725008234"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.03.007","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification and validation of interferon-driven gene signature as a predictor of response to methotrexate in juvenile idiopathic arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}